FDA Commissioner Gottlieb and CDER Director Janet Woodcock described new steps to help advance the adoption of continuous manufacturing, which include the release of draft guidance. The guidance provides information on the quality considerations for continuous manufacturing of small molecule, solid oral drug products that are regulated by CDER, with recommendations on how applicants should address these considerations in their applications.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
